-
1دورية أكاديمية
المؤلفون: Yoshihito Kogure, MD, PhD, Akiko Kada, MPH, Hiroya Hashimoto, PhD, Shinji Atagi, MD, Yuichi Takiguchi, MD, Hideo Saka, MD, Noriyuki Ebi, MD, Akira Inoue, MD, Takayasu Kurata, MD, Yuka Fujita, MD, Yoichi Nishii, MD, Hidetoshi Itani, MD, Takeo Endo, MD, Akiko M. Saito, MD, Takuo Shibayama, MD, Nobuyuki Yamamoto, MD, Akihiko Gemma, MD
المصدر: JTO Clinical and Research Reports, Vol 4, Iss 6, Pp 100514- (2023)
مصطلحات موضوعية: Squamous-cell non–small cell lung cancer, Elderly, Immune checkpoint inhibitors, Nab-paclitaxel, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S266636432300053XTest; https://doaj.org/toc/2666-3643Test
-
2دورية أكاديمية
المؤلفون: Yuan Feng, Wei Sun, Jie Zhang, Yang Wang, Jinfeng Chen, Xinying Liu, Liang Wang, Shaolei Li, Chao Lv, Fangliang Lu, Jianzhi Zhang, Yang Hong, Shanshan Xiao, Tao Wang, Raymond Jiao, Ziping Wang, Liping Qi, Nan Li, Yue Yang, Dongmei Lin, Jian Fang
المصدر: Thoracic Cancer, Vol 13, Iss 3, Pp 442-452 (2022)
مصطلحات موضوعية: major pathological response, neoadjuvant anti‐PD‐1 antibody with chemotherapy, squamous cell non‐small‐cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Cheng Fang, Chu Zhang, Wei-Qing Zhao, Wen-Wei Hu, Jun Wu, Mei Ji
المصدر: BMC Medical Genomics, Vol 12, Iss 1, Pp 1-6 (2019)
مصطلحات موضوعية: Squamous-cell non-small cell lung cancer, Immunotherapy, TP53, KRAS, Internal medicine, RC31-1245, Genetics, QH426-470
وصف الملف: electronic resource
العلاقة: http://link.springer.com/article/10.1186/s12920-019-0592-6Test; https://doaj.org/toc/1755-8794Test
-
4
المؤلفون: Yuan Feng, Wei Sun, Jie Zhang, Yang Wang, Jinfeng Chen, Xinying Liu, Liang Wang, Shaolei Li, Chao Lv, Fangliang Lu, Jianzhi Zhang, Yang Hong, Shanshan Xiao, Tao Wang, Raymond Jiao, Ziping Wang, Liping Qi, Nan Li, Yue Yang, Dongmei Lin, Jian Fang
المصدر: Thoracic Cancer
Thoracic Cancer, Vol 13, Iss 3, Pp 442-452 (2022)مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Lung Neoplasms, major pathological response, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Original Articles, General Medicine, B7-H1 Antigen, Neoadjuvant Therapy, Oncology, neoadjuvant anti‐PD‐1 antibody with chemotherapy, Carcinoma, Squamous Cell, Humans, Original Article, Immune Checkpoint Inhibitors, Lung, squamous cell non‐small‐cell lung cancer, RC254-282
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0063015f807154b3733ee39a6e4dcd14Test
https://doi.org/10.1111/1759-7714.14280Test -
5
المؤلفون: Wei-Qing Zhao, Cheng Fang, Jun Wu, Mei Ji, Wenwei Hu, Chu Zhang
المصدر: BMC Medical Genomics, Vol 12, Iss 1, Pp 1-6 (2019)
BMC Medical Genomicsمصطلحات موضوعية: Male, 0301 basic medicine, Lung Neoplasms, endocrine system diseases, medicine.medical_treatment, Case Report, Pembrolizumab, medicine.disease_cause, Deoxycytidine, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Positron Emission Tomography Computed Tomography, TP53, Lung, Genetics (clinical), High-Throughput Nucleotide Sequencing, Middle Aged, Squamous-cell non-small cell lung cancer, 030220 oncology & carcinogenesis, Adenocarcinoma, Drug Therapy, Combination, KRAS, Immunotherapy, medicine.drug, lcsh:Internal medicine, lcsh:QH426-470, Antibodies, Monoclonal, Humanized, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Biomarkers, Tumor, Genetics, medicine, ROS1, Humans, Lung cancer, lcsh:RC31-1245, neoplasms, business.industry, Sequence Analysis, DNA, medicine.disease, Gemcitabine, Immune checkpoint, respiratory tract diseases, lcsh:Genetics, 030104 developmental biology, Mutation, Cancer research, Tumor Suppressor Protein p53, Tomography, X-Ray Computed, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3c6cbd27c10d7916bd9ac344581b288Test
http://link.springer.com/article/10.1186/s12920-019-0592-6Test -
6تقرير
المصدر: A Randomized, Controlled, Open-label Phase II/III Study of The Safety, Tolerability and Efficacy of JMT101 Combined With Docetaxel / HB1801 in Patients With sqNSCLC
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06319313Test
-
7تقرير
المصدر: Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC(neoSCORE Ⅱ):A Prospective, Randomized, Open-Label, Multi-Center Phase 3 Trial
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05429463Test
-
8تقرير
المصدر: A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Initial Efficacy of HLX35 (Recombinant Human Anti-EGFR and Anti-4-1BB Bispecific Antibody) in Patients With Advanced or Metastatic Solid Tumors
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05360381Test
-
9تقرير
المصدر: A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Bemarituzumab Monotherapy and Combination With Other Anti-Cancer Therapy in Subjects With Squamous-Cell Non-Small-Cell Lung Cancer (FORTITUDE-201)
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05267470Test
Other URLs: http://www.amgentrials.comTest
-
10تقرير
المصدر: A Randomized, Double-blind, Multicenter Phase III Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04439890Test